Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 2
2020 6
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470 Free article. Review.
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. Although there has been much speculation about the therapeutic value of cannabi …
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is r …
Anorexia and the Cancer Patient.
Johannes CM, Musser ML. Johannes CM, et al. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):837-854. doi: 10.1016/j.cvsm.2019.04.008. Epub 2019 Jun 6. Vet Clin North Am Small Anim Pract. 2019. PMID: 31176457 Review.
Inappetence often is multifactorial, complicating treatment. Cancer-related anorexia/cachexia syndrome is a metabolic, paraneoplastic syndrome characterized by decreased food intake, involuntary weight loss, and loss of fat and muscle. ...
Inappetence often is multifactorial, complicating treatment. Cancer-related anorexia/cachexia syndrome is a metabolic, paraneo …
Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R, Ambwani SR, Singh S. Kaur R, et al. Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's disease, Alzheimer's disease and Tour …
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, …
[The potential use of cannabidiol in the therapy of metabolic syndrome].
Kleiner D, Ditrói K. Kleiner D, et al. Orv Hetil. 2012 Apr 1;153(13):499-504. doi: 10.1556/OH.2012.29308. Orv Hetil. 2012. PMID: 22430005 Review. Hungarian.
Cannabidiol, a cannabinoid and serotonin receptor antagonist, may alleviate hyperphagia without the side effects of rimonabant (for example depression and reduced insulin sensitivity). ...It may also be effective in fighting ischaemic diseases, the most harmful complicatio
Cannabidiol, a cannabinoid and serotonin receptor antagonist, may alleviate hyperphagia without the side effects of rimonabant (for e
Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome.
Salles ÉL, Khodadadi H, Jarrahi A, Ahluwalia M, Paffaro VA Jr, Costigliola V, Yu JC, Hess DC, Dhandapani KM, Baban B. Salles ÉL, et al. J Cell Mol Med. 2020 Nov;24(21):12869-12872. doi: 10.1111/jcmm.15883. Epub 2020 Oct 15. J Cell Mol Med. 2020. PMID: 33058425 Free PMC article.
In a follow-up study to our recent findings indicating the potential of Cannabidiol (CBD) in the treatment of acute respiratory distress syndrome (ARDS), here we show for the first time that CBD may ameliorate the symptoms of ARDS through up-regulation of apelin, a …
In a follow-up study to our recent findings indicating the potential of Cannabidiol (CBD) in the treatment of acute respiratory distr …
Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS, Mahajan UB, Agrawal YO, Patil KR, Patil CR, Ojha S, Sharma C, Goyal SN. Patil AS, et al. Biomed Pharmacother. 2020 Dec;132:110889. doi: 10.1016/j.biopha.2020.110889. Epub 2020 Oct 28. Biomed Pharmacother. 2020. PMID: 33113429 Free article. Review.
In the present article, we reviewed the role of natural cannabinoid compounds in metabolic disorders and related complications. We studied variety of a plant-derived cannabinoids in treating the metabolic syndrome including stoutness, fatty acid liver disease …
In the present article, we reviewed the role of natural cannabinoid compounds in metabolic disorders and related complications. We st …
Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet.
Assa-Glazer T, Gorelick J, Sela N, Nyska A, Bernstein N, Madar Z. Assa-Glazer T, et al. Cannabis Cannabinoid Res. 2020 Sep 2;5(3):202-214. doi: 10.1089/can.2020.0013. eCollection 2020. Cannabis Cannabinoid Res. 2020. PMID: 32923658 Free PMC article.
Introduction: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several studies in mice and humans have implicated the involvement of the gut microbiome in NAFLD. While cannabis …
Introduction: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, di …
Emerging Use of Epidiolex (Cannabidiol) in Epilepsy.
Abu-Sawwa R, Scutt B, Park Y. Abu-Sawwa R, et al. J Pediatr Pharmacol Ther. 2020;25(6):485-499. doi: 10.5863/1551-6776-25.6.485. J Pediatr Pharmacol Ther. 2020. PMID: 32839652 Free PMC article. Review.
The first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication, Epidiolex, was approved in the United States by the FDA on June 25, 2018. Its approval for patients 2 years of age with Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS) …
The first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication, Epidiolex, was approved in the United States by …
Electrochemical sensing: A prognostic tool in the fight against COVID-19.
Kotru S, Klimuntowski M, Ridha H, Uddin Z, Askhar AA, Singh G, Howlader MMR. Kotru S, et al. Trends Analyt Chem. 2021 Mar;136:116198. doi: 10.1016/j.trac.2021.116198. Epub 2021 Jan 23. Trends Analyt Chem. 2021. PMID: 33518850 Free PMC article. Review.
The biomarkers discussed in this paper are C-reactive protein (CRP), interleukins (ILs), tumour necrosis factor alpha (TNFalpha), interferons (IFNs), glutamate, breath pH, lymphocytes, platelets, neutrophils and D-dimer. Metabolic syndrome is also discussed as comor …
The biomarkers discussed in this paper are C-reactive protein (CRP), interleukins (ILs), tumour necrosis factor alpha (TNFalpha), interferon …
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.
Scharf EL. Scharf EL. Cannabis Cannabinoid Res. 2017 Oct 1;2(1):259-264. doi: 10.1089/can.2017.0033. eCollection 2017. Cannabis Cannabinoid Res. 2017. PMID: 29098188 Free PMC article. Review.
Introduction: The endocannabinoid system (ECS) regulates functions throughout human physiology, including neuropsychiatric, cardiovascular, autonomic, metabolic, and inflammatory states. The complex cellular interactions regulated by the ECS suggest a potential for vascula …
Introduction: The endocannabinoid system (ECS) regulates functions throughout human physiology, including neuropsychiatric, cardiovascular, …
24 results